These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15480426)

  • 1. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
    Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
    Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB.
    Li Y; Liu W; Xing G; Tian C; Zhu Y; He F
    Cell Signal; 2005 Aug; 17(8):985-96. PubMed ID: 15894171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno ; Harada K; Yoshida H; Sato M
    Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
    Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
    Wang H; Sun X; Luo Y; Lin Z; Wu J
    FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
    Tomoda K; Kubota Y; Kato J
    Nature; 1999 Mar; 398(6723):160-5. PubMed ID: 10086358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
    Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
    Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
    Karimpour S; Lou J; Lin LL; Rene LM; Lagunas L; Ma X; Karra S; Bradbury CM; Markovina S; Goswami PC; Spitz DR; Hirota K; Kalvakolanu DV; Yodoi J; Gius D
    Oncogene; 2002 Sep; 21(41):6317-27. PubMed ID: 12214272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A; Niki T; Moriyama S; Funata N; Moriyama H; Nishimura Y; Tsuchida R; Kato JY; Fukayama M
    Pathol Int; 2004 Sep; 54(9):675-81. PubMed ID: 15363035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.
    Claret FX; Hibi M; Dhut S; Toda T; Karin M
    Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding.
    Dai YS; Hao J; Bonin C; Morikawa Y; Cserjesi P
    J Neurosci Res; 2004 Jun; 76(5):613-22. PubMed ID: 15139020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasin interacts with Jab1 and influences breast cancer progression.
    Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
    Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.